← Evidence map

ArticleClinical proteomics2020

Development of robust targeted proteomics assays for cerebrospinal fluid biomarkers in multiple sclerosis.

Astrid Guldbrandsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32963504